Patent ID: 11872309
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 14:
15. The method of claim 1, wherein the oral liquid suspension comprises:
2.5±0.25% w/v 2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate (topiramate);
0.10±0.01% w/v methylparaben;
0.03±0.003% w/v sodium benzoate powder;
0.08±0.008% w/v saccharin sodium dihydrate;
3.00±0.3% w/v 70% solution of sorbitol;
2.25±0.3% w/v propylene glycol;
5±0.5% w/v glycerin (99% natural);
1.26±0.15% w/v microcrystalline cellulose and colloidal silicon dioxide;
0.18±0.02% w/v sodium carboxymethyl cellulose (medium viscosity, 2% aqueous solution at 25° C. 400-800 centipoises);
0.18±0.02% w/v xanthan gum NF
0.20±0.02% w/v cherry flavor (natural & artificial)
0.002±0.0002% w/v FD&C Red #40
0.0002±0.00002% w/v FD&C Yellow #6
79.67±8.0% w/v purified water
5±0.5% w/v polyethylene glycol 400
0.25±0.03% w/v sodium phosphate dibasic (dried)
0.5±0.05% w/v sucralose.